Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)
Leukemia Research, 05/29/2012
Clinical Article
Ceesay MM et al. – The findings suggest that CHOP–Zenapax (CHOP–Z) is safe and in those who achieve a complete response it was associated with prolonged overall survival.



